Drug Patents owned by Hospira

1. List of Precedex drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8455527 HOSPIRA Methods of treatment using a dexmedetomidine premix formulation
Jan, 2032

(8 years from now)

US8648106 HOSPIRA Dexmedetomidine premix formulation
Jan, 2032

(8 years from now)

US9616049 HOSPIRA Dexmedetomidine premix formulation
Jan, 2032

(8 years from now)

US8242158 HOSPIRA Dexmedetomidine premix formulation
Jan, 2032

(8 years from now)

US10016396 HOSPIRA Dexmedetomidine premix formulation
Jan, 2032

(8 years from now)

US9320712 HOSPIRA Dexmedetomidine premix formulation
Jan, 2032

(8 years from now)

US8338470 HOSPIRA Dexmedetomidine premix formulation
Jan, 2032

(8 years from now)

US8648106

(Pediatric)

HOSPIRA Dexmedetomidine premix formulation
Jul, 2032

(9 years from now)

US8242158

(Pediatric)

HOSPIRA Dexmedetomidine premix formulation
Jul, 2032

(9 years from now)

US8455527

(Pediatric)

HOSPIRA Methods of treatment using a dexmedetomidine premix formulation
Jul, 2032

(9 years from now)

US8338470

(Pediatric)

HOSPIRA Dexmedetomidine premix formulation
Jul, 2032

(9 years from now)

US9320712

(Pediatric)

HOSPIRA Dexmedetomidine premix formulation
Jul, 2032

(9 years from now)

US9616049

(Pediatric)

HOSPIRA Dexmedetomidine premix formulation
Jul, 2032

(9 years from now)

Drugs and Companies using DEXMEDETOMIDINE HYDROCHLORIDE ingredient

Market Authorisation Date: 17 December, 1999

Treatment: Use for sedation

Dosage: INJECTABLE;INJECTION

How can I launch a generic of PRECEDEX before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in